Physicians' Academy for Cardiovascular Education

Expanding the role of lipid management: Current and Future

3' education - Oct. 25, 2011


Dr. Kees Hovingh, internist, Academic Medical Centre, Amsterdam, The Netherlands, discusses current and future targets in lipid management.
Questions to be addressed in this PACE expert opinion are:
  • What is the interaction between lipid particles and onset of atherogenicity?
  • What can we learn from clinical trials to define current and future targents in management of dyslipidemia?


The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: